SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-24-078173
Filing Date
2024-06-27
Accepted
2024-06-27 08:39:48
Documents
1
Period of Report
2024-06-26

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 4119
  Complete submission text file 0000950170-24-078173.txt   5698
Mailing Address 117 KENDRICK STREET SUITE 450 NEEDHAM MA 02494
Business Address 117 KENDRICK STREET SUITE 450 NEEDHAM MA 02494 617-916-5445
Candel Therapeutics, Inc. (Issuer) CIK: 0001841387 (see all company filings)

IRS No.: 522214851 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O SIGA TECHNOLOGIES, INC. 31 EAST 62ND STREET NEW YORK NY 10065
Business Address
Nabel Gary J. (Reporting) CIK: 0001867450 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40629 | Film No.: 241075527